These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32787374)

  • 1. A case of durvalumab-treated double primary cancers of the colon and lung.
    Pu X; Xu T; Ge C; He Y; Yang X; Chang P
    Ann Palliat Med; 2020 Sep; 9(5):3614-3622. PubMed ID: 32787374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon metastasis from lung adenocarcinoma with BRAF V600E mutation: A case report.
    Luo Y; Mou K; Wang J; Luo J; Peng L; Ye H; Lin S
    Front Immunol; 2022; 13():970879. PubMed ID: 36003386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term response with durvalumab after chemoradiotherapy for pulmonary pleomorphic carcinoma: A case report.
    Yorozuya T; Taya T; Yasuda K; Nagano Y; Shioya M; Chiba H; Takahashi H
    Thorac Cancer; 2020 Apr; 11(4):1090-1093. PubMed ID: 32045109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
    Garassino MC; Cho BC; Kim JH; Mazières J; Vansteenkiste J; Lena H; Corral Jaime J; Gray JE; Powderly J; Chouaid C; Bidoli P; Wheatley-Price P; Park K; Soo RA; Huang Y; Wadsworth C; Dennis PA; Rizvi NA;
    Lancet Oncol; 2018 Apr; 19(4):521-536. PubMed ID: 29545095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].
    Mignard X; Antoine M; Moro-Sibilot D; Dayen C; Mennecier B; Gervais R; Amour E; Milleron B; Morin F; Zalcman G; Wislez M
    Rev Mal Respir; 2018 Nov; 35(9):983-988. PubMed ID: 30243521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of a patient with non-small cell lung cancer and interstitial lung disease with durvalumab: a case report.
    Tao H; Li F; Li R; Han X; Hu Y
    Ann Palliat Med; 2020 Sep; 9(5):3623-3628. PubMed ID: 32648466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durvalumab for the treatment of non-small cell lung cancer.
    Mezquita L; Planchard D
    Expert Rev Respir Med; 2018 Aug; 12(8):627-639. PubMed ID: 29958099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Case of Local Recurrence of Descending Colon Cancer with Ileus Obstruction and Lung, Liver and Brain Metastasis].
    Tomita R; Fujisaki S; Sakurai K; Azuhata T; Takamoto Y
    Gan To Kagaku Ryoho; 2018 Apr; 45(4):679-681. PubMed ID: 29650833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC.
    Antonia SJ; Balmanoukian A; Brahmer J; Ou SI; Hellmann MD; Kim SW; Ahn MJ; Kim DW; Gutierrez M; Liu SV; Schöffski P; Jäger D; Jamal R; Jerusalem G; Lutzky J; Nemunaitis J; Calabrò L; Weiss J; Gadgeel S; Bhosle J; Ascierto PA; Rebelatto MC; Narwal R; Liang M; Xiao F; Antal J; Abdullah S; Angra N; Gupta AK; Khleif SN; Segal NH
    J Thorac Oncol; 2019 Oct; 14(10):1794-1806. PubMed ID: 31228626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
    Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
    Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metachronous triple primary neoplasms with primary prostate cancer, lung cancer, and colon cancer: A case report.
    Feng Y; Zhong M; Zeng S; Xiao D; Liu Y
    Medicine (Baltimore); 2018 Jun; 97(26):e11332. PubMed ID: 29953024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
    Zandberg DP; Algazi AP; Jimeno A; Good JS; Fayette J; Bouganim N; Ready NE; Clement PM; Even C; Jang RW; Wong S; Keilholz U; Gilbert J; Fenton M; Braña I; Henry S; Remenar E; Papai Z; Siu LL; Jarkowski A; Armstrong JM; Asubonteng K; Fan J; Melillo G; Mesía R
    Eur J Cancer; 2019 Jan; 107():142-152. PubMed ID: 30576970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sister Mary Joseph's nodule as a presenting sign of internal malignancy.
    Dodiuk-Gad R; Ziv M; Loven D; Schafer J; Shani-Adir A; Dyachenko P; Rozenman D
    Skinmed; 2006; 5(5):256-8. PubMed ID: 16957443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durvalumab in non-small-cell lung cancer patients: current developments.
    Mezquita L; Planchard D
    Future Oncol; 2018 Feb; 14(3):205-222. PubMed ID: 29140105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anlotinib combined with durvalumab in a patient with recurrent multifocal brain metastases of small cell lung cancer after definitive concurrent chemoradiotherapy and palliative radiotherapy of the lung and brain: a case report.
    Wu Y; Zhang T; Liu Y; Wang J; Bi N
    Ann Palliat Med; 2021 Feb; 10(2):2379-2386. PubMed ID: 33725780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Complete Response to Computed Tomography-Guided Celiac Plexus Neurolysis of Pain Associated with Postoperative Recurrence of Colon Cancer].
    Yabe N; Masuda M; Tamura E; Morishige S; Saito A; Harada Y; Miyabayashi M; Sakimoto Y; Tajima Y; Takenoya T; Oto I; Yoshikawa T; Osumi K; Murai S
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1877-1879. PubMed ID: 30692384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: A case of advanced duodenal adenocarcinoma in complete remission after chemotherapy combined with targeted therapy and radiotherapy.
    Zhang Z; Lei Y; Wang D; Yang L; Lou C
    Front Oncol; 2022; 12():968110. PubMed ID: 36353566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].
    Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Hasegawa H; Kitagawa Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1834-6. PubMed ID: 24393938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.
    Antonia S; Goldberg SB; Balmanoukian A; Chaft JE; Sanborn RE; Gupta A; Narwal R; Steele K; Gu Y; Karakunnel JJ; Rizvi NA
    Lancet Oncol; 2016 Mar; 17(3):299-308. PubMed ID: 26858122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229).
    Chia S; Bedard PL; Hilton J; Amir E; Gelmon K; Goodwin R; Villa D; Cabanero M; Tu D; Tsao M; Seymour L
    Oncologist; 2019 Nov; 24(11):1439-1445. PubMed ID: 31420468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.